Trade Summary

6 days ago, Sukhtian Faisal Ghiath, serving as Dir at Outlook Therapeutics, Inc. (OTLK), purchased 95,398 shares at $1.05 per share, for a total transaction value of $99,996.18. Following this transaction, Sukhtian Faisal Ghiath now holds 220,972 shares of OTLK.

This purchase represents a 75.97% increase in Sukhtian Faisal Ghiath's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, July 29, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, July 29, 2026 at 3:19 PM ET, meaning the disclosure happened on the same day as the trade.

Outlook Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.